Circulation: Heart Failure
Published by Wolters Kluwer Health
ISSN : 1941-3289 eISSN : 1941-3297
Abbreviation : Circ. Heart Fail.
Aims & Scope
Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance.
As a primarily clinical journal, few basic and preclinical studies are ultimately published.
Those that will be considered are novel, and significantly and directly advance the field of heart failure.
The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models.
Less than 15% of submitted articles are ultimately published.
Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 8.4 |
2024 | 7.80 |
Journal Rank
Year | Value |
---|---|
2024 | 695 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 2443 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 3.037 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 146 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Forecasting the Impact of Heart Failure in the United States
Citation: 2310
Authors: Paul A., Nancy M., Larry A., David A., Javed, Gregg C., John S., Olga, Marvin A., Thomas M., Graham, Michael, Ileana L., Justin G.
-
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Citation: 936
Authors: Barry A., Rick A., Paul, Carolyn S.P., Margaret M.
-
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
Citation: 591
Authors: Enrico, Maria, Eric D., Cristina, David H., Michela, Matthias G., Karin, Jukka, Javid J., Patrizia, Ornella E., Heinz-Peter, Carsten, Leslie T., Paolo G.
-
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Citation: 537
Authors: Dirk, Diana, Mario, Christine, K., F., J., C., Paul, Alexander, Wolfgang, Heinz-Peter, Carsten
-
Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest
Citation: 438
Authors: Prashant, Zain, Richard, Daniel, Robb D.
-
Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction
Citation: 420
Authors: Vojtech, Seok-Jae, Margaret M., Rosita, Grace, Barry A.
-
Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?
Citation: 418
Authors: Marco, Beth, Luca, Hengrui, Christopher, Valentina, Barbara, Valentina, Silvia, Carlo, Gad, Livio
-
Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction
Citation: 415
Authors: Ambarish, Akhil, Dharam J., Sunil, Jalaj, Dalane, Benjamin D., Mark, Jarett D.
-
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Citation: 405
Authors: Mathew S., Sabahat, Thibaud, Sharmila, Brian M., Marianna, Martha, Arnt V., Isabelle, Jose, Candida, Claudio, Frederick L., Ronald, Giampaolo
-
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Citation: 380
Authors: Lili, Willem P.T., Maxi, Eelke M., Harry, Bahram, Pim, Bertram, Irwin J., Jasper A., Dirk J., Ruud A., Wiek H., Herman H.W., Rudolf A.